Scientists at Sanaria and Seattle Children’s Research Institute’s Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, designed to provide high-level protection with just one dose.
Insights Into the First Psychedelic-Assisted Therapy Guidelines With Hadas Alterman | Psychedelic Spotlight
Hadas provides insights into her role at APPA and the organization’s mission to seamlessly integrate psychedelic medicine into the U.S. healthcare system. We also dive
September 21, 2023